David M. Denton - Feb 27, 2024 Form 4 Insider Report for PFIZER INC (PFE)

Role: Chief Financial Officer & EVP
Signature: Susan E. Grant, by power of atty., for David M. Denton
Stock symbol: PFE
Transactions as of: Feb 27, 2024
Transactions value $: $0
Form type: 4
Date filed: 2/28/2024, 05:00 PM
Previous filing: Jun 1, 2023
Next filing: Jun 3, 2024
SEC: View on sec.gov

Derivative Securities (e.g., puts, calls, warrants, options, convertible securities)

Type	Sym	Class	Transaction	Value $	Shares	Change %	* Price $	Shares After	Date	Underlying Class	Amount	Exercise Price	Ownership	Footnotes
transaction	PFE	Stock Appreciation Rights	Award	$0	+161K		$0.00	161K	Feb 27, 2024	Common Stock	161K	$26.89	Direct	F1
transaction	PFE	Stock Appreciation Rights	Award	$0	+142K		$0.00	142K	Feb 27, 2024	Common Stock	142K	$26.89	Direct	F2

Showing 1 to 2 of 2 entries

* An asterisk sign (*) next to the price indicates that the price is likely invalid.

Explanation of Responses:

Id	Content
F1	The stock appreciation rights, which are subject to certain vesting requirements, will be settled in shares of Pfizer common stock on the fifth anniversary of the date of grant.
F2	The stock appreciation rights, which are subject to certain vesting requirements, will be settled in shares of Pfizer common stock on the seventh anniversary of the date of grant.